Government buying office
Barda - Aspr / Daappo / Barda Dcma
Administration For Strategic Preparedness And Response · Health And Human Services, Department Of
Office code 75A501
Contracts awarded
149
since Feb 2021 · $7.4B
Companies that won
95
5% of awards to small businesses
One-bid contracts
75%
64 of 85 competed awards drew one bid
Set aside
3%
of awards reserved for small businesses or programs
Awards by fiscal year
FY2021
1 · $2.7M
FY2024
99 · $3.2B
FY2025
25 · $1.5B
FY2026
24 · $2.7B
What it buys
Health R&D Services; Health Care Services; Experimental Development
53 awards · $1.6B · 85% one bid
Drugs And Biologicals
23 awards · $2.0B
Health R&D Services; Health Care - Other; Applied Research
20 awards · $930M · 50% one bid
Health R&D Services; Health Care Services; Applied Research
14 awards · $392M · 83% one bid
Health R&D Services; Health Care Services; Basic Research
7 awards · $447M
Health R&D Services; Health Care Services; R&D Administrative Expenses
6 awards · $350M · 100% one bid
Support- Professional: Program Management/Support
3 awards · $791M · 33% one bid
Specialized Medical Support
3 awards · $415M · 100% one bid
Who wins here
Glaxosmithkline LLC
13 wins · $156M
Advanced Technology International
10 wins · $582M
Battelle Memorial Institute
10 wins · $105M
Seqirus INC.
8 wins · $430M
Sanofi Vaccines US INC.
8 wins · $233M
J&M Global Solutions LLC
3 wins · $1.8M · small business
Kaleo, INC.
2 wins · $375M
Booz Allen Hamilton INC.
2 wins · $169M
Ending in the next 12 months
This office will likely re-bid these. The incumbent and last price are public now.
Other Transaction: Sustainment Of Ppe Capacities - Nitrile Butadiene Rubber
Advanced Technology International · ends Apr 2027 · $51M
Ot Task Order 6 - Dxr2
Advanced Technology International · ends Jun 2027 · $30M
Bone Marrow Cryo-Banking To Treat Acute Radiation Syndrome In A Mass-Casualty Emergency
Ossium Health, INC. · ends May 2027 · $21M · won with 1 bid
The Purpose Of This Hhs Task Order Is To Procure Services For The Storage And Stability Of Bulk Lots & Final Containers Of-Adjuvant( As03) Covid-19 Funds.
Glaxosmithkline LLC · ends May 2027 · $14M
The Purpose Of This Requirement Is To Provide Medical Countermeasures (Mcms), Such As Vaccines And Adjuvants, For Pandemic Preparedness And Response Or As Required In Response To A Hhs Designated
Sanofi Pasteur INC. · ends May 2027 · $13M
Multiplex, Accurate, Rapid, Testing For You (Marty)
Revvity Health Sciences, INC. · ends Dec 2026 · $9.3M · won with 1 bid
Execution Of The Clinical Method Comparison Study And Regulatory Submission Required To Be Granted Clia-Waiver From The Fda For Febridx Response To Baa-23-100-Sol-00004
Lumos Diagnostics, INC · ends Nov 2026 · $8.3M · won with 1 bid
The Purpose Of This Requirement Is To Provide Medical Countermeasures (Mcms), Such As Vaccines And Adjuvants, For Pandemic Preparedness And Response Or As Required In Response To A Hhs Designated
Seqirus INC. · ends May 2027 · $8.1M
Want to sell to Barda - Aspr / Daappo / Barda Dcma?
ZukoBid shows its open contracts with what it paid last time, who usually bids, and what to bid, and preps the bid for you.
From federal contract award records (SAM.gov), base awards over $10K since fiscal year 2024, updated daily. "One-bid" counts only competed contracts (open to any bidder) that report how many bids came in.
ZukoBid is an independent service, not affiliated with or endorsed by any government agency. Figures come from public records and may contain errors; always check the official listing before you bid.